Form D · Pharmaceuticals
Theraly Fibrosis, Inc.
Germantown, MD · CIK 0001733346
Offering snapshot reported Jun 22, 2018 · SEC filing
- Reported sold
- $4.94M Offering amount: $5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 7, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 22, 2018 | Initial | $4,939,495 | No comparison | 4 | SEC filing |
| Mar 12, 2018 | Initial | $700,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315205
Source: Form D, filed Jun 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seulki Lee | Director |
| Junghee Lim | Director |
| Keele Park | Director |
| Viktor Roschke | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
20271 Goldenrod Road, Suite 2097
Germantown, MD, 20876
Germantown, MD, 20876